Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Molecular Genetics and Metabolism Reports|December 6, 2023
Pharmacodynamics, safety, tolerability and pharmacokinetics of a single oral dose of an engineered phenylalanine ammonia-lyase in patients with phenylketonuriaTimothy Nicholas Fazio, Louise Healy, Tim Heise, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 19, 2017
Estimation of Circulating Drug Metabolite Exposure in Human Using In Vitro Data and Physiologically Based Pharmacokinetic Modeling: Example of a High Metabolite/Parent Drug RatioR Scott Obach, Jian Lin, Emi Kimoto, et al.
Endocrinology, Diabetes & Metabolism Case Reports|October 12, 2018
Mitochondrial disease: an uncommon but important cause of diabetes mellitusMing Li Yee, Rosemary Wong, Mineesh Datta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 3, 2010
Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative databaseKaori Ito, Brian Corrigan, Qinying Zhao, et al.
Clinical Pharmacology in Drug Development|August 30, 2024
Meta-Analysis of Noncompartmental Pharmacokinetic Parameters to Evaluate the Impact of CYP2C19 and CYP2C9 Genetic Polymorphisms on Abrocitinib ExposureLuke Fostvedt, Jian Liu, Xiaoxing Wang, et al.
The AAPS Journal|March 18, 2018
PharmTeX: a LaTeX-Based Open-Source Platform for Automated Reporting WorkflowChristian Hove Rasmussen, Mike K Smith, Kaori Ito, et al.
Clinical Pharmacology and Therapeutics|January 4, 2020
Hippocampal Neuroimaging-Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open DataDaniela J Conrado, Jackson Burton, Derek Hill, et al.
Clinical Pharmacology and Therapeutics|January 20, 2020
Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open DataDaniela J Conrado, Sridhar Duvvuri, Hugo Geerts, et al.
Clinical Pharmacokinetics|June 13, 2026
Elranatamab Population Pharmacokinetics and Exposure-Response for Cytokine Release Syndrome in Patients with Relapsed or Refractory Multiple MyelomaJennifer E Hibma, Donald Irby, Alan Liu, et al.
Clinical and Translational Science|July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling AnalysisDaniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.
Pageof 6